Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Simard

Showing results (71-80 of 290) with videos related to

Pageof 29
Sort By:
Human Genetics|June 26, 2023
Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian contextPalmira Granados Moreno, Terese Knoppers, Ma'n H Zawati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test resultMichel Dorval, Geneviève Gauthier, Elizabeth Maunsell, et al.
Frontiers in Genetics|October 7, 2017
Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision MakersGratien Dalpé, Ida Ngueng Feze, Shahad Salman, et al.
The Prostate|November 6, 2003
Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortiumSteve Edwards, Julia Meitz, Ros Eles, et al.
Genes|March 3, 2019
Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle ControlYosr Hamdi, Martin Leclerc, Martine Dumont, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
Cancers|September 28, 2024
Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation ProjectSoo-Jin Seung, Nicole Mittmann, Zharmaine Ante, et al.
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Human Genetics|May 11, 2005
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer familiesHélène Vézina, Francine Durocher, Martine Dumont, et al.
BMC Cancer|October 3, 2006
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer familiesFrancine Durocher, Yvan Labrie, Penny Soucy, et al.
Pageof 29

Showing results (71-80 of 290) with videos related to

Sort By:
Pageof 29
Human Genetics|June 26, 2023
Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian contextPalmira Granados Moreno, Terese Knoppers, Ma'n H Zawati, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test resultMichel Dorval, Geneviève Gauthier, Elizabeth Maunsell, et al.
Frontiers in Genetics|October 7, 2017
Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision MakersGratien Dalpé, Ida Ngueng Feze, Shahad Salman, et al.
The Prostate|November 6, 2003
Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortiumSteve Edwards, Julia Meitz, Ros Eles, et al.
Genes|March 3, 2019
Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle ControlYosr Hamdi, Martin Leclerc, Martine Dumont, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
Cancers|September 28, 2024
Evaluating Real World Health System Resource Utilization and Costs for a Risk-Based Breast Cancer Screening Approach in the Canadian PERSPECTIVE Integration and Implementation ProjectSoo-Jin Seung, Nicole Mittmann, Zharmaine Ante, et al.
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Human Genetics|May 11, 2005
Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer familiesHélène Vézina, Francine Durocher, Martine Dumont, et al.
BMC Cancer|October 3, 2006
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer familiesFrancine Durocher, Yvan Labrie, Penny Soucy, et al.
Pageof 29